Cerity Partners’s Insight Molecular Diagnostics IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.9K Buy
+11,947
New +$52.9K ﹤0.01% 3348

Other funds holding IMDX

Cerity Partners's IMDX Position: Q3 2026 in Review

Cerity Partners opened a new position in Insight Molecular Diagnostics (IMDX) in Q3 2026: 11,947 shares worth $42.9K. The stake represents ﹤0.01% of the portfolio and ranks #3348 among its holdings.

44 funds tracked by Wall St. Rank hold IMDX as of Q3 2026.

  • Cerity Partners held 11,947 shares of Insight Molecular Diagnostics worth $42.9K as of Q3 2026.
  • Insight Molecular Diagnostics was a new Cerity Partners position in Q3 2026.
  • Insight Molecular Diagnostics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #3348 holding.
  • 44 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.